Model Developed for Predicting Missed Appointments in Primary Care
By Elana Gotkine HealthDay Reporter
Medically reviewed by Drugs.com

TUESDAY, July 29, 2025 -- The gradient boost model achieves the best performance for predicting no-shows and late cancellations in primary care practices, according to a study published in the July/August issue of the Annals of Family Medicine.
Wen-Jan Tuan, M.P.H., from the Penn State College of Medicine in Hershey, and colleagues conducted a retrospective longitudinal study leveraging geolinked clinical, care utilization, socioeconomic, and climate data from 15 family medicine clinics in Pennsylvania from January 2019 to June 2023. Machine learning models were developed to predict appointment outcomes; contributing factors for no-shows or late cancellations were identified at the population and patient levels.
The analysis included 109,328 patients and 1,118,236 appointments, including 77,322 and 75,545 (6.9 and 6.8 percent) no-shows and late cancellations, respectively. The best performance was achieved with the gradient boost model, with an area under the receiver operating characteristic curve of 0.852 and 0.921 for predicting no-shows and late cancellations, respectively. There was no bias detected against patient characteristics. The most important predictor of missed appointments was schedule lead time (i.e., number of days from a patient's appointment request to the appointment date).
"This analytical framework lays a foundation for health systems to assess individual risk of missed appointments and design personalized strategies to help patients adhere to primary care appointments," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-07-30 12:00
Read more

- Radiation Therapy Can Promote Amphiregulin, Which Increases Growth of Metastases
- Alopecia Areata Associated With Severe Psychosocial Impact
- The Gut-Healthy Secret Weapon Hiding in Your Sauerkraut
- Popular YoCrunch Yogurt Recalled Over Plastic Pieces in Packaging
- Racial Differences Seen in Prostate Cancer Care Quality
- New Framework Reclassifies Nearly 20 Percent of People as Having Obesity
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions